Is Immunovant, Inc. (IMVT) a Buy, Sell, or Hold?
NASDAQ : IMVT
Immunovant, Inc.
$40.26 USD
$1.3 (3.34%)
- Volume
- 852.56K
- Average Volume
- 1.91M
- Market Capitalization
- $8.27B
- P/E Ratio
- -14.48
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $41.23
- Year Low
- $14.32
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.09
IMVT vs. The Competition
| Properties | IMVT | ACAD | AKRO | CRNX |
|---|---|---|---|---|
| Market Cap | $8.27B | $4.38B | $4.5B | $8.88B |
| Shares Outstanding | $205.31M | $171.24M | $82.32M | $105.84M |
| P/E Ratio | -14.48 | 11.48 | -19.87 | -16.32 |
| EPS | -2.48 | 2.2 | -2.72 | -4.77 |
| Day Low | 38.01 | 25.2 | 54.52 | 83.81 |
| Day High | 40.46 | 25.835 | 54.65 | 84.015 |
| Year Low | 14.32 | 19.69 | 21.34 | 25.83 |
| Year High | 41.23 | 28.35 | 58.4 | 84 |
| Average Price 50 | 34.3242 | 22.8646 | 53.0613 | 44.8728 |
| Average Price 200 | 26.92385 | 23.41245 | 48.19307 | 43.98177 |
| Volume | 852.56K | 1.14M | 11.61M | 5.37M |
| Average Volume | - | - | - | - |